Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer
NCT07731607
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
48
Enrollment
OTHER
Sponsor class
Conditions
MMRd Endometrial Cancer of Stage I~II
Interventions
DRUG:
Sintilimab monotherapy
Sponsor
Wang Jianliu
Collaborators
[object Object]